The prostate-specific antigen, or PSA, testing market is growing as prostate-cancer awareness, ageing populations, healthcare screening initiatives, and diagnostic innovation increase worldwide. The market was valued at USD 16.38 billion in 2024 and is projected to reach USD 25.6 billion by 2032, growing at a CAGR of 5.73%. 1186
A PSA test is a blood test that measures the level of...
Bangla